UBS Group »

Xortx Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Xortx Therapeutics (XRTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Xortx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xortx Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xortx Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $20k 17k 1.13
2024-09-30 $31k 19k 1.64